KIT and acute myeloid leukemia: RTKs contribute significantly to leukemogenesis, (Sharawat et al., 2013) with the stem cell factor receptor (c-Kit or CD117) and FMS-like kinase-3 (FLT3 or CD135) being key proliferative RTKs in AML (Sharawat et al., 2013).